Stock screener

IMNM

Conviction 92HealthcareScan · Mon, Aug 10, 2026
IMNM$25.67+2.56%
ResistanceSupportVol 14Insider buyInsider sell
63 bars
2
3
2
5
Vol MA14 1.15M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Immunome Inc.PHARMACEUTICAL PREPARATIONSwww.immunome.com ↗
Price25.67
Change+2.56%
Gap+0.52%
Rel volume3.20×
Avg volume1.16M
Avg $ vol27.34M
SMA 2023.35
SMA 5021.59
SMA 20021.23
Price vs 50+18.88%
Price vs 200+20.89%
MA stackbullish
50/200 cross—
Supertrendup · 22.36
RSI (14)68
MACD hist0.23
MACD crossbull · 4d
Stoch %K / %D84 / 81
ADX (14)33
+DI / −DI29 / 12
RSI divergence—
MACD divergence—
ATR %+4.69%
ADR %4.83%
52w high26.97
52w low8.99
From 52w high-4.82%
Above 52w low+185.54%
New 52w highNo
SqueezeOff
Bollinger width21.45%
%B0.96
Donchian pos84.47%
Donchian high26.42
Donchian low21.59
AVWAP (52w high)21.75
vs AVWAP high+18.05%
AVWAP (52w low)19.81
vs AVWAP low+29.57%
OBV trendUp
Chaikin MF (20)0.17
Today vs 20d3.20×
Avg vol (14d)1.15M
Avg vol (20d)1.16M
Avg $ vol (20d)27.34M
Market cap2.91B
RS 3m (vs SPY)+7.10%
RS 6m (vs SPY)-9.82%
RS line new highNo
Trend template7/8
Technical rank77.0
1 week+11.56%
1 month+9.94%
3 months+14.39%
6 months+3.18%
1 year+160.08%
YTD+23.29%
P/E-13.69
P/B4.94
P/S418.84
P/FCF-14.49
EPS-2.43
Div yield—
ROE-36.08%
ROA-34.27%
Debt/Eq0.00
Current21.68
EV/EBITDA-10.49
Gross margin—
Net margin—
Rev growth-23.23%
EPS growth27.50%
Price target35.36
Target upside37.75%
Analyst ratingBuy
Institutional109.22%
Ent. value2.32B
Revenue0
Net income-53.84M
Gross profit—
Free cash flow-200.6M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out113.25M
Employees177
ListedFri, Oct 2, 2020
Free float77.44M
Float %84.4%
Short interest17.24M
Days to cover10.5d
Short volume75.9%
Squeeze score100 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.48 vs −$0.60
Last surprise+20.0% beat
Setup gradeA+
Conviction92 / 100
Pattern quality—
Tech rank77.0 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance25.71
Support19.71
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in IMNM

All disclosures →
No recent disclosed trades by Congress in IMNM. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IMNM · 10 buys

InsiderSideShares
Higgins Jack
Chief Scientific Officer · Common Stock · 2026-07-23
Grant38.25K
Higgins Jack
Chief Scientific Officer · Employee Stock Option (right to buy) · 2026-07-23
Grant76.5K
Horn Kinney
CHIEF BUSINESS OFFICER · Common Stock · 2026-07-23
Grant31.25K
Horn Kinney
CHIEF BUSINESS OFFICER · Employee Stock Option (right to buy) · 2026-07-23
Grant62.5K
SIEGALL CLAY B
President and CEO · Common Stock · 2026-07-23
Grant180K
SIEGALL CLAY B
President and CEO · Employee Stock Option (right to buy) · 2026-07-23
Grant360K
Stoneman Sandra G.
CHIEF LEGAL OFFICER & GC · Common Stock · 2026-07-23
Grant38.25K
Stoneman Sandra G.
CHIEF LEGAL OFFICER & GC · Employee Stock Option (right to buy) · 2026-07-23
Grant76.5K
Rosett Max
Chief Financial Officer · Common Stock · 2026-07-23
Grant47.25K
Rosett Max
Chief Financial Officer · Employee Stock Option (right to buy) · 2026-07-23
Grant94.5K

SEC filings

EDGAR filings in IMNM · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.